Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Aug 9, 2016 · 10-Q · 40 days after period end · 0001564590-16-023663
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | -$62.30M | -$41.85M | -$33.87M | -$19.05M |
| EPS Diluted | -$1.35 | -$1.01 | -$0.85 | -$0.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 9, 2016 · 40 d after period end
